This apparently contradictory clinical/pathological finding remains to be further explored because, although Piezo2 overexpression was already noted in aggressive carcinomas [13,14,15,16,17,18,19,25], this is the first study including a cohort of more than 100 patients with complete morphological and clinical evaluation. This evidence concerns the gene PIEZO2 and carcinoma.